review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00434343 |
P698 | PubMed publication ID | 3882257 |
P2093 | author name string | A G Bosanquet | |
P2860 | cites work | Aggregation of chlorambucil in vitro may cause misinterpretation of protein binding data | Q30666941 |
THE MECHANISM OF ACTION OF ALKYLATING AGENTS. | Q34540646 | ||
A novel dye exclusion method for testing in vitro chemosensitivity of human tumors | Q34661920 | ||
Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity | Q34662056 | ||
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs | Q34662387 | ||
Interaction of human serum albumin with anticancer agents in vitro | Q36043868 | ||
An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia | Q36047694 | ||
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells | Q36047840 | ||
In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution | Q36624499 | ||
Differential plus polarographic determination of submicrogram quantities of carmustine and related compounds in biological samples | Q36624825 | ||
NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide b | Q38581308 | ||
A method for the measurement of L-phenylalanine mustard in the mouse and dog by high-pressure liquid chromatography | Q39126226 | ||
Degradation of Carmustine in Aqueous Media | Q39161154 | ||
Mechanism of Hydrolysis of Halogenated Nitrosoureas | Q39219217 | ||
Kinetics and Mechanism of Chlorambucil Hydrolysis | Q39270321 | ||
The stability of melphalan in the presence of chloride ion | Q39297527 | ||
The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously as a bolus or by continuous infusion | Q39375122 | ||
Comparison of the properties of metabolites of CCNU | Q39840577 | ||
Stability studies of drugs used in intravenous solutions. I | Q72356672 | ||
Photolytic degradation of adriamycin | Q72457747 | ||
Degradation of chlorambucil in aqueous solution—influence of human albumin binding | Q72499238 | ||
A new light on the photo-decomposition of the antitumour drug DTIC | Q72523823 | ||
Bioactivity of cyclophosphamide preparations | Q72554121 | ||
Demonstration of nitrogen coordination in metal-bleomycin complexes by electron spin-echo envelope spectroscopy | Q72633337 | ||
Photolability of bleomycin and its complexes | Q72649312 | ||
Development of an antibody to actinomycin D and its application for the detection of serum levels by radioimmunoassay | Q72658912 | ||
Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro | Q72683658 | ||
Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro | Q72717264 | ||
Photoactivity of bleomycin | Q72721915 | ||
Effect of step-down heating on the cytotoxicity of adriamycin, bleomycin, and cis-diamminedichloroplatinum | Q72729885 | ||
4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft | Q72764419 | ||
Chemosensitivity tests by a miniclone technique | Q72840383 | ||
EXPERIMENTS ON DETERMINATION OF MELPHALAN BY FLUORESCENCE. INTERACTION WITH PROTEIN AND VARIOUS SOLUTIONS | Q76831778 | ||
Some interactions of nitrogen mustards with constituents of human blood serum | Q78986057 | ||
Rapid assay for plasma chlorambucil and phenyl acetic mustard using reversed-phase liquid chromatography | Q93859396 | ||
Quantitative determination of adriamycin and daunorubicin-handling of blood and plasma samples | Q71022650 | ||
Human tumor cloning: feasibility and clinical correlations | Q71037288 | ||
Stability and compatibility of antitumor agents in glass and plastic containers | Q71059223 | ||
Determination of busulfan in plasma by GC-MS with selected-ion monitoring | Q71107137 | ||
Stability of fluorouracil in amber glass bottles | Q71151966 | ||
High-pressure liquid chromatography of vitamin A metabolites and analogs | Q71165611 | ||
Gas chromatography, gas chromatography--mass spectrometry, and high-pressure liquid chromatography of carotenoids and retinoids | Q71165615 | ||
In vitro activation of dacarbazine (DTIC) for a human tumor cloning system | Q71207081 | ||
Application of a microsomal drug activation system in a human tumor cloning assay | Q71219907 | ||
Stability of carmustine in the presence of sodium bicarbonate | Q71229511 | ||
Protein mediated chemical reactions of chloroethylnitrosoureas | Q71236055 | ||
Lipophilic drugs and lipoproteins: partitioning effects on chloroethylnitrosourea reaction rates in serum | Q71244564 | ||
Effect of temperature on the cytotoxicity of vindesine, amsacrine, and mitoxantrone | Q71247347 | ||
Physicochemical characteristics of ferric adriamycin complexes | Q71250378 | ||
Effect of inline filtration on the potency of low-dose drugs | Q71255507 | ||
Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines | Q71256453 | ||
Mechlorethamine hydrochloride solutions and ointment. Prolonged stability and biological activity | Q71257646 | ||
Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate | Q71303574 | ||
Epoxide formation from (2S,3S)-threitol 1,4-bismethanesulfonate. Preparation and biological activity of (2S,3S)-1,2-epoxy-3,4-butanediol 4-methanesulfonate | Q71592828 | ||
Correlation of cellular tritiated thymidine incorporation with soft agar clonogenicity in chemosensitivity testing of human neuroblastoma cells | Q71661633 | ||
Avoiding common flaws in stability and compatibility studies of injectable drugs | Q71816224 | ||
Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity | Q71822484 | ||
Concomitant adsorption and stability of some anthracycline antibiotics | Q72055403 | ||
Toxicity, hæmatological effects and anti-tumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol | Q72210727 | ||
The Modes of Decomposition of 1,3-Bis(2-chloroethyl)-1-nitrosourea and Related Compounds | Q72249071 | ||
Pharmacology of Nitrosourea Antitumor Agents1 | Q39851904 | ||
Effect of light and oxygen on neocarzinostatin stability and DNA-cleaving activity | Q39859181 | ||
Photoreactivity of bleomycin and its implications | Q40109200 | ||
Chloroethylnitrosourea cancer chemotherapeutic agents | Q40252831 | ||
L-phenylalanine mustard (L-PAM): the first 25 years | Q40292728 | ||
Effect of briefly heating cyclophosphamide solutions | Q40314424 | ||
Human tumor colony assay and chemosensitivity testing. | Q41435066 | ||
Assay of anti-cancer drugs in tissue culture; conditions affecting their ability to incorporate 3H-leucine after drug treatment | Q41452548 | ||
High-Performance Liquid Chromatographic Analysis of Cyclophosphamide | Q41455213 | ||
Direct cloning of human breast cancer in soft agar culture | Q41455622 | ||
An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level | Q42244220 | ||
Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers. | Q42253967 | ||
Chemosensitivity of established human bladder carcinoma cell lines in vitro | Q42259332 | ||
Macromolecular interactions of [14C-ring]melphalan in blood | Q42264153 | ||
Degradation of chlorambucil in aqueous solution | Q42272819 | ||
Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells | Q42374670 | ||
In vitro chemosensitivity of human bladder cancer | Q42664811 | ||
Separation and Quantitation of Possible Degradation Products of Procarbazine Hydrochloride in Its Dosage Form | Q43771888 | ||
Adsorption of fluorouracil on glass surfaces | Q43773302 | ||
High-resolution nuclear magnetic resonance investigations of the chemical stability of cyclophosphamide and related phosphoramidic compounds | Q43809501 | ||
Pharmacokinetics of the absorption, distribution, and elimination of melphalan in the dog | Q43936449 | ||
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy | Q44069260 | ||
The concept of drug dose for in vitro studies with chemotherapeutic agents | Q45277092 | ||
Stability of injectable medications after reconstitution | Q45760877 | ||
Chemosensitivity of human neoplasms with in vitro clone formation. Experience at the University of Southern California - Los Angeles County Medical Center | Q46620046 | ||
Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea | Q48456673 | ||
Errors in oncolytic agent stability study. | Q51851356 | ||
2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone I: Kinetics in aqueous solutions by high-performance liquid chromatography. | Q52435503 | ||
Statistical prediction of drug stability based on nonlinear parameter estimation. | Q52693684 | ||
Influence of pH on the cytotoxic activity of chlorambucil. | Q53561618 | ||
Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. | Q53578028 | ||
Kinetics of chlorambucil hydrolysis using high-pressure liquid chromatography. | Q53849952 | ||
Stability of Nitrosourea Solutions | Q54056913 | ||
Adsorption of some antibiotics and other drugs on silicone-coated glass surfaces. | Q54349024 | ||
In vitro determination of tumour chemosensitivity in haematological malignancies. | Q54462842 | ||
Normalization of in vitro sensitivity testing of human tumor clonogenic cells. | Q54478164 | ||
Prediction of the response to chemotherapy in acute leukemia by a short-term test in vitro. | Q54480068 | ||
Chemical and biological stability of anticancer drugs used in a human tumor clonogenic assay. | Q54481445 | ||
DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. | Q54539329 | ||
Decomposition of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) in aqueous solution. | Q54562007 | ||
Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. | Q54579562 | ||
Photodegradation of dacarbazine | Q66700598 | ||
2-chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea | Q66912732 | ||
Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum(II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)methylamine | Q66957012 | ||
Direct in vitro photoaffinity labeling of DNA with daunorubicin, adriamycin, and rubidazone | Q66971108 | ||
Reactions of 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous solution | Q66974043 | ||
Medications not to be refrigerated | Q66978382 | ||
Application of a simple high—performance liquid chomatographic method for the determination of melphalan in the presence of its hydrolysis products | Q66993883 | ||
Serum displacing agents in cancer chemotherapy | Q67014090 | ||
Formulation of three nitrosoureas for intravenous use | Q67262035 | ||
Thermal and Photolytic Decomposition of Methotrexate in Aqueous Solutions | Q67318921 | ||
Hydrolysis and Protein Binding of Melphalan | Q67318972 | ||
Radiobiological techniques applied to environmental problems | Q67432245 | ||
Degradation of carmustine in mixed solvent and nonaqueous media | Q67657473 | ||
Effect of inline filtration on the potency of drugs administered intravenously | Q67707081 | ||
Metabolism of cyclophosphamide by rat hepatic microsomes | Q68754435 | ||
Chemical stability of cyclophosphamide in parenteral solutions | Q69488151 | ||
Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography | Q69802216 | ||
Prospective clinical trial of a human tumor cloning system | Q70244888 | ||
Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis | Q70282556 | ||
Interactions between drugs and intravenous delivery systems | Q70327757 | ||
Stability of carmustine for topical application | Q70391695 | ||
Quantitative analysis of procarbazine, procarbazine metabolites and chemical degradation products with application to pharmacokinetic studies | Q70403319 | ||
Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay | Q70424206 | ||
In vitro degradation of L-phenylalanine mustard (L-PAM) | Q70424985 | ||
Degradation of melphalan in aqueous solutions--influence of human albumin binding | Q70456054 | ||
Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line | Q70480165 | ||
The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukaemia cells in vitro | Q70505622 | ||
Measurement of plasma melphalan at therapeutic concentrations using isocratic high-performance liquid chromatography | Q70544043 | ||
Pharmacologic pitfalls in the human tumor clonogenic assay | Q70658477 | ||
2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone II: Isolation and characterization of degradation products | Q70690536 | ||
The effect of macromolecules upon the rates of hydrolysis of aromatic nitrogen mustard derivatives | Q70701061 | ||
Analysis of procarbazine and metabolites by gas chromatography-mass spectrometry | Q70730606 | ||
Anticancer drug testing in vitro: use of an activating system with the human tumor stem cell assay | Q70735454 | ||
Quantitative analysis of melphalan and its major hydrolysate in patients and animals by reversed-phase high-performance liquid chromatography | Q70764844 | ||
Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy | Q70782481 | ||
Pharmacokinetics and bioavailability of cyclophosphamide from oral formulations | Q70793210 | ||
Influence of pH and serum on the effectivity of antineoplastic agents in vitro | Q70863145 | ||
Possible incompatibility of doxorubicin hydrochloride with aluminum | Q70930841 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 83-95 | |
P577 | publication date | 1985-01-01 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents | |
P478 | volume | 14 |